Compositions and methods for organ preservation
View Patent ↗Disclosed herein are solutions for use with machine perfusion of one or more organs. In some embodiments, the solutions comprise acellular cross-linked hemoglobin in a physiologically acceptable medium. Also disclosed herein are methods for machine perfusion of one or more organs, for example utilizing the disclosed perfusion solutions. In some embodiments, the methods include perfusing an organ with an oxygenated solution (such as the disclosed solutions) which is at a temperature between about 12-37° C., for example at a temperature of about 21° C.
1. A method for machine perfusion of a liver, comprising perfusing the liver through the hepatic artery in a pulsatile flow and through the portal vein in a continuous flow with a solution comprising 3-4 g/dL acellular cross-linked hemoglobin and 10-40 g/L hydroxyethyl starch in a physiologically acceptable medium, wherein the solution has a pH of about 7.55-7.85 at room temperature, an osmolality of about 290-300 mOsm/kg, and a colloid osmotic pressure of about 35-65 mm Hg, wherein the solution is oxygenated, and wherein the solution and the organ are maintained at a temperature of about 21° C. throughout the perfusion.
2. The method of claim 1 , wherein the solution comprises about 3.25 g/dL cross-linked hemoglobin, 28.25 mM NaCl, 1 mM KCl, 18.75 mM KH 2 PO 4 , 60 mM sodium gluconate, 6.75 mM sodium lactate, 3.75 mM magnesium gluconate, 0.725 mM CaCl 2 dihydrate, 15.62 mM NaOH, 3.75 mM adenine, 7.5 mM dextrose, 2.25 mM glutathione, 7.5 mM HEPES, 3.75 mM ribose, 22.5 mM mannitol, 37.5 g/L hydroxyethyl starch, and 50 mg/dL N-acetyl-L-cysteine.
3. A method for machine perfusion of an organ, comprising perfusing the organ with a solution comprising 3-4 g/dL acellular cross-linked hemoglobin and 10-40 g/L hydroxyethyl starch in a physiologically acceptable medium, wherein the solution has a pH of about 7.55-7.85 at room temperature, an osmolality of about 290-300 mOsm/kg, and a colloid osmotic pressure of about 35-65 mm Hg, wherein the solution is oxygenated, and wherein the solution and the organ are maintained at a temperature of about 21° C. throughout the perfusion.
4. The method of claim 3 , wherein the organ comprises one or more of a heart, lung, liver, kidney, pancreas, small intestine, limb, extremity, tissue graft, or portion thereof.
5. The method of claim 3 , wherein at least a portion of the solution is delivered to the organ in a pulsatile flow.
6. The method of claim 3 , wherein the solution is oxygenated with a gas mixture having an FiO 2 of 40-80%.
7. The method of claim 3 , wherein the organ is a liver and the solution is delivered to the liver through the hepatic artery in a pulsatile flow and to the portal vein in a continuous flow.
8. The method of claim 7 , wherein the hepatic artery pressure is about 15-20 mm Hg.
9. The method of claim 7 , wherein the portal vein pressure is about 3-5 mm Hg.
10. The method of claim 3 , wherein the method comprises perfusing the organ prior to transplantation, perfusing the organ during surgery or treatment, or perfusing the organ prior to or during collection of cells from the organ.
11. The method of claim 1 , wherein the solution comprises 3-4 g/dL cross-linked hemoglobin, 25-85 mM NaCl, 1-3 mM KCl, 6-20 mM KH 2 PO 4 , 20-70 mM sodium gluconate, 5-21 mM sodium lactate, 1-4 mM magnesium gluconate, 0.6-1.2 mM CaCl 2 dihydrate, 11-16 mM NaOH, 1-4 mM adenine, 2-8 mM dextrose, 0.5-3 mM glutathione, 2-8 mM HEPES, 1-4 mM ribose, 7-30 mM mannitol, 10-40 g/L hydroxyethyl starch, and 40-160 mg/dL N-acetyl-L-cysteine.
12. The method of claim 3 , wherein the solution comprises 3-4 g/dL cross-linked hemoglobin, 25-85 mM NaCl, 1-3 mM KCl, 6-20 mM KH 2 PO 4 , 20-70 mM sodium gluconate, 5-21 mM sodium lactate, 1-4 mM magnesium gluconate, 0.6-1.2 mM CaCl 2 dihydrate, 11-16 mM NaOH, 1-4 mM adenine, 2-8 mM dextrose, 0.5-3 mM glutathione, 2-8 mM HEPES, 1-4 mM ribose, 7-30 mM mannitol, 10-40 g/L hydroxyethyl starch, and 40-160 mg/dL N-acetyl-L-cysteine.